YFYngve Forslin

Yngve Forslin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yngve Forslin has a total of 4 co-authors. Here are the top co-authors by number of shared publications:

  • Anders Kjellman

    Department of Clinical Science, Intervention and Technology, Division of Urology, Karolinska Institute, Stockholm, Sweden; Department of Urology, Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden

    1 shared publication
  • Galyna Zinko

    Department of Radiology, Karolinska University Hospital, 141 86 Stockholm, Sweden

    1 shared publication
  • Marianna Hrebenyuk

    CLINTEC (The Department of Clinical Science, Intervention and Technology), Karolinska University, 141 86 Stockholm, Sweden

    1 shared publication
  • Martin Delle

    Department of Clinical Science, Intervention and Technology (CLINTEC), Division of Interventional Radiology, Karolinska Institute, Stockholm, Sweden

    1 shared publication

Latest Publications

  • Open Access

    Factors that Affect Outcome of Ultrasound-Guided Radiofrequency Ablation of Renal Masses

    by Galyna Zinko, Marianna Hrebenyuk, Anders Kjellman, Yngve Forslin, Martin Delle

    The purpose of this study was to examine the factors influencing the efficacy and safety of the ultrasound-guided radiofrequency ablation of renal tumors. Between January 2010 and December 2018, 159 patients with renal tumors treated with ultrasound-guided percutaneous radiofrequency ablation at our institution were included in this study. Biopsies were performed for histopathological analysis prior to each ablation. Patients underwent computed tomography follow-ups at 3, 6, and 12 months and were subsequently observed on an annual basis. The primary efficacy rate (i.e., residual tumor), local tumor progression, morbidity and mortality, and possible outcome predictors (age, body mass index, gender, tumor size, tumor location, tumor characteristics, ablation temperature, and reported technical problems) were analyzed using binary logistic regression. At the first follow-up, 3 months after ablation, the primary efficacy rate was 79%. Two percent of the tumors showed local tumor progression during the whole follow-up. Tumor proximity to the collecting system and the final temperature in the ablation region were associated with the occurrence of residual tumor (OR = 2.85, p = 0.019 and OR = 4.23, p = 0.006, respectively). A similar trend was shown for tumors larger than 3 cm (p = 0.066). A short distance to the collecting system and the ablation temperature were significantly related to the occurrence of residual tumors after the radiofrequency ablation of small renal masses. The ultrasound guidance used in our study has a lower primary efficacy rate than the computed tomography guidance used in comparable studies.